Malik Ritu, Pancholi Ketan, Melzer Andreas
Institute of Medical Sciences and Technology, University of Dundee, Dundee, UK.
School of Mechanical and Systems Engineering, Newcastle University, Newcastle upon Tyne, UK.
Nanobiomedicine (Rij). 2016 Oct 5;3:1849543516670806. doi: 10.1177/1849543516670806. eCollection 2016 Jan-Dec.
Liposome-microbubble conjugates are considered as better targeted drug delivery vehicles compared to microbubbles alone. The microbubble in the integrated drug delivery system delivers the drug intracellularly on the target, whereas the liposome component allows loading of high drug dose and extravasation through leaky vasculature. In this work, a new high yielding microbubble production method was used to prepare microbubbles for formulation of the liposome-conjugated drug delivery system. In formulation process, the prepared liposome of 200 nm diameter was attached to the microbubble surface using the avidin-biotin interaction. The analysis of the confocal scanning laser microscope images showed that approximately 8 × 10 microbubbles per millilitre (range: 2-7 μm, mean size 5 ± 0.5 μm) can be efficiently conjugated to the liposomes. The method of conjugation was found to be effective in attaching liposome to microbubbles.
与单纯的微泡相比,脂质体 - 微泡偶联物被认为是更好的靶向药物递送载体。集成药物递送系统中的微泡在靶标处将药物递送至细胞内,而脂质体成分允许装载高剂量药物并通过渗漏的脉管系统外渗。在这项工作中,采用了一种新的高产微泡生产方法来制备用于脂质体偶联药物递送系统制剂的微泡。在制剂过程中,使用抗生物素蛋白 - 生物素相互作用将制备的直径为200 nm的脂质体附着于微泡表面。共聚焦扫描激光显微镜图像分析表明,每毫升约8×10个微泡(范围:2 - 7μm,平均大小5±0.5μm)可以有效地与脂质体偶联。发现偶联方法在将脂质体附着于微泡方面是有效的。